Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antagonism of Endogenous Opioids: Use in Interpretation of Injections

NCT06666621 is registered in ClinicalTrials.gov with Middle Tennessee Research Institute as lead sponsor.

NCT NCT06666621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06666621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antagonism of Endogenous Opioids: Use in Interpretation of Injections
Lead sponsor
Middle Tennessee Research Institute
Phase
Phase 4
Overall status
Recruiting
Start date
August 22, 2024
Completion date
February 28, 2026
Enrollment
33 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

low back pain, zygapophyseal joint arthritis